Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Theratechnologies Inc. - Common Shares
(NQ:
THTX
)
1.470
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Theratechnologies Inc. - Common Shares
< Previous
1
2
3
4
5
6
Next >
Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
February 28, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
February 28, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV
February 22, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says
November 17, 2022
Via
Benzinga
Theratechnologies: Q3 Earnings Insights
October 13, 2022
Theratechnologies (NASDAQ:THTX) reported its Q3 earnings results on Thursday, October 13, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Theratechnologies Announces Path to Resume TH1902 Clinical Development
February 16, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update
February 14, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Inc. (NASDAQ:THTX) Investor Alert: Investigation over Possible Violations of Securities Laws
January 17, 2023
San Diego, CA -- (SBWIRE) -- 01/17/2023 -- An investigation on behalf of investors of Theratechnologies Inc. (NASDAQ:THTX) shares over potential securities laws violations by Theratechnologies Inc. and...
Via
SBWire
Open Letter to Shareholders from CEO Paul Levesque
January 04, 2023
Theratechnologies Announces Fiscal Year 2023 Guidance and Operating Plan’s Key Objectives
From
Theratechnologies
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
December 06, 2022
Tuesday's session saw 167 companies set new 52-week lows.
Via
Benzinga
Dow Drops 100 Points; Asana Shares Plummet
December 02, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday.
Via
Benzinga
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session
December 02, 2022
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.
Via
Benzinga
Gold Down 1%; Samsara Shares Spike Higher
December 02, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
Dow Tumbles 300 Points After US Economy Adds 263,000 Jobs
December 02, 2022
U.S. stocks traded lower this morning, with the Dow Jones falling more than 300 points on Friday following the release of jobs data for November.
Via
Benzinga
Theratechnologies Announces Update from Ongoing TH1902 Study
December 01, 2022
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,...
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays
October 26, 2022
From
Theratechnologies
Via
GlobeNewswire
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Via
Benzinga
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
October 13, 2022
From
Theratechnologies
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Upgrades
Via
Benzinga
Earnings Scheduled For October 13, 2022
October 13, 2022
Companies Reporting Before The Bell • Valens Co (NASDAQ:VLNS) is estimated to report quarterly loss at $0.17 per share on revenue of $26.75 million.
Via
Benzinga
Earnings Preview: Theratechnologies
October 12, 2022
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Thursday, 2022-10-13. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium
October 12, 2022
From
Theratechnologies
Via
GlobeNewswire
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
October 05, 2022
Losers
Via
Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 04, 2022
Good morning, investor! It's time for a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday!
Via
InvestorPlace
Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday.
Via
Benzinga
Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population
October 03, 2022
From
Theratechnologies
Via
GlobeNewswire
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.